AYR WELLNESS INC - AYRWF STOCK NEWS

Ayr Wellness Inc. (OTCQX: AYRWF) announced approval for adult-use cannabis sales in New Jersey, allowing its three dispensaries in Central Jersey to serve this market. Until now, the area had limited access to adult-use cannabis, with only two dispensaries available. Ayr's entry into the adult-use market comes as New Jersey is projected to generate $2.3 billion in legal cannabis sales by 2026, positioning itself as a significant player in the U.S. cannabis industry.

Ayr Wellness has announced the launch of sales from its new cultivation facility in Phoenix, Arizona, marking a significant operational milestone. The 80,000 sq. ft. facility began operations in December 2021 and has yielded around 75 g/sq. ft. from 22 strains. Ayr also launched its STiX Pre-Roll brand in Arizona, featuring popular strains in both conventional and infused pre-rolls. The new offerings aim to enhance the Kynd brand presence in the state while allowing Ayr to meet growing demand as feedback from wholesale partners has been overwhelmingly positive.

Ayr Wellness announced that the Massachusetts Cannabis Control Commission granted a final license for the sale of adult-use cannabis at its Back Bay dispensary in Boston. This marks the first adult-use dispensary in one of Boston's most desirable neighborhoods. CEO Jonathan Sandelman highlighted the location's proximity to high-traffic areas, expecting it to be a major retail site. Ayr has executed Host Community Agreements with Boston and plans to open the dispensary in June 2022, while aiming for final approvals for two additional locations in Greater Boston.

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) has opened its 47th dispensary in Florida, located in Clermont, near Orlando. This new 4,000 square foot store offers a full range of cannabis products, including concentrates, edibles, and high-quality flower, including Kynd and Walking STiX brands. Since acquiring Liberty Health Sciences in February 2021, Ayr has expanded its Florida presence significantly, responding to a growing market with over 715,000 patients enrolled. Florida's cannabis market is projected to generate $3.4 billion annually by 2026.

XS Financial Inc. has announced that it has upsized its lease facility with Ayr Wellness to $37.4 million, including an immediate drawdown of $12 million. This increases total usage to over $33.1 million. Brad Asher, CFO of AYR, emphasized the smooth collaboration with XS Financial, while David Kivitz, CEO of XS Financial, expressed excitement over expanding their relationship as AYR's needs grow. AYR is a leading U.S. cannabis operator focused on high-quality cannabis production.

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) will hold a conference call on May 26, 2022, at 8:30 a.m. ET to discuss its first-quarter results for the period ended March 31, 2022. CEO Jonathan Sandelman, Co-COO Jennifer Drake, and CFO Brad Asher will lead the call, followed by a Q&A session. Financial results will be released before the call. Dial-in information includes toll-free numbers and a webcast link for broader accessibility. A replay of the call will be available for one month.

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) has expanded its product offerings in Massachusetts with the launch of its premium flower brand Kynd and the introduction of Entourage vapes in Ohio. Kynd began sales on April 29 at Sira Naturals dispensaries, featuring new strains with premium genetics. The Entourage vapes, available to medical patients in Ohio, include six unique strains. Ayr aims to increase brand presence in key markets, with Kynd being a leading flower brand in multiple states. Massachusetts and Ohio's cannabis markets are projected to generate significant revenue growth by 2026.

Ayr Wellness Inc. announced the opening of its 46th Florida dispensary in southern Tampa, enhancing its presence in a significant market. The dispensary spans roughly 3,000 square feet and features a wide range of products, including the recently launched Kynd premium flower and Walking STIX pre-rolls.

Following its acquisition of Liberty Health Sciences, Ayr has opened 15 additional locations, demonstrating strong growth. Florida’s medical marijuana program currently serves ~710,000 patients and is projected to reach $3.4 billion in annual sales by 2026, indicating a robust market for Ayr.

Ayr Wellness Inc. (AYRWF) has expanded its product range at Liberty Health Sciences dispensaries in Florida by launching its premium flower brand, Kynd. Sales commenced this week, featuring six strains: Blueberry Headband, Extraterrestrial Bananas, True OG, Purple Trainwreck, Polyjuice #4, and Lemon Haze. Ayr aims to enhance its high-quality offerings in Florida, following the introduction of several other brands in the past nine months. The Florida medical marijuana market is thriving, with over 707,933 registered patients as of April 15, 2022.